INNOVATE BIOPHARMACEUTICALS, INC. Business Finance Contracts & Agreements

59 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Forbearance and Amendment Agreement among High Trail Special Situations LLC, 9 Meters Biopharma, Inc., and NAIA Rare Diseases, LLC
Forbearance Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
Amendment No. 1 to Forbearance Agreement among High Trail Special Situations LLC, 9 Meters Biopharma, Inc., and Naia Rare Diseases, LLC
Forbearance Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
Forbearance Agreement among High Trail Special Situations LLC, 9 Meters Biopharma, Inc., and Naia Rare Diseases, LLC dated April 26, 2023
Forbearance Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2023
Description of Securities Registered Under Section 12 of the Exchange Act – 9 Meters Biopharma, Inc.
Equity Distribution Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2023
Securities Purchase Agreement between 9 Meters Biopharma, Inc. and Purchasers dated March 13, 2023
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2023
Placement Agent Common Stock Purchase Warrant between 9 Meters Biopharma, Inc. and H.C. Wainwright & Co., LLC
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2023
Pre-Funded Common Stock Purchase Warrant between 9 Meters Biopharma, Inc. and Holder (March 2023)
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2023
Common Stock Purchase Warrant Agreement between 9 Meters Biopharma, Inc. and Holder (March 2023)
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2023
First Amendment to Amended and Restated Senior Secured Convertible Note Due 2025 between 9 Meters Biopharma, Inc. and High Trail Special Situations LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2023
Amended and Restated Senior Secured Convertible Note due 2025 between 9 Meters Biopharma, Inc. and High Trail Special Situations LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2022
9 Meters Biopharma, Inc. Senior Secured Convertible Note Due 2025 with High Trail Special Situations LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2022
Securities Purchase Agreement between 9 Meters Biopharma, Inc. and Investors (June 2022)
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2022
9 Meters Biopharma, Inc. 2022 Stock Option Grant and Award Agreement
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2022
Asset Purchase Agreement between 9 Meters Biopharma, Inc. and Lobesity LLC (July 19, 2021)
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2021
Underwriting Agreement between 9 Meters Biopharma, Inc. and Underwriters (Citigroup, William Blair, Truist Securities) dated March 30, 2021
Underwriting Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2021
Underwriting Agreement between 9 Meters Biopharma, Inc. and Underwriters (William Blair & Company, L.L.C. and Truist Securities, Inc.) dated December 11, 2020
Underwriting Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2020
Amendment No. 1 to Sales Agreement between 9 Meters Biopharma, Inc. and Truist Securities, Inc.
Modification Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2020
RDD Pharma Ltd. Notice of Option Grant to Purchase Preferred Shares
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2020
Registration Rights Agreement between Innovate Biopharmaceuticals, Inc. and Investors (April 29, 2020)
Registration Rights Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2020
Securities Purchase Agreement between Innovate Biopharmaceuticals, Inc. (to be renamed 9 Meters Biopharma, Inc.) and Investors, dated April 29, 2020
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2020
Preferred Stock Purchase Warrant Agreement between 9 Meters Biopharma, Inc. and Holder
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2020
Description of Innovate Biopharmaceuticals, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2020
Amendment to Short-Term Common Stock Purchase Warrant between Innovate Biopharmaceuticals, Inc. and Holder
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2020
Securities Purchase Agreement between Innovate Biopharmaceuticals, Inc. and Atlas Sciences, LLC (January 10, 2020)
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2020
Convertible Promissory Note between Innovate Biopharmaceuticals, Inc. and Atlas Sciences, LLC dated January 10, 2020
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2020
Warrant Exchange Agreement between Innovate Biopharmaceuticals, Inc. and Holder of May 1, 2019 Common Stock Purchase Warrant
Exchange Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2019
Form of Securities Purchase Agreement, dated April 29, 2019, by and among the Company and the purchasers party thereto
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Form of Placement Agent Warrant
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2019
Form of Warrant
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2019
Amendment to Securities Purchase Agreement between Innovate Biopharmaceuticals, Inc. and Purchasers (April 25, 2019)
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Securities Purchase Agreement between Innovate Biopharmaceuticals, Inc. and Purchasers (March 17, 2019)
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Note Purchase Agreement, dated March 8, 2019, by and between the Company and Atlas Sciences, LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2019
Note issued to Atlas Sciences, LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2019
Option to Purchase Senior Convertible Note, by and between the Company and Gustavia Capital Partners LLC and/or its affiliates dated as of January 7, 2019
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Senior Convertible Note between Innovate Biopharmaceuticals Inc. and Gustavia Capital Partners LLC (January 26, 2018)
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018
Amendment and Exchange Agreement between Innovate Biopharmaceuticals Inc. and Note Holder
Exchange Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2018
Innovate Biopharmaceuticals Inc. Restricted Stock Purchase Agreement under 2015 Stock Incentive Plan
Stock Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NC
2018
Asset Purchase Agreement between Innovate Biopharmaceuticals Inc. and Repligen Corporation (SecreFlo Assets)
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2018
Innovate Biopharmaceuticals, Inc. Common Stock Certificate (Specimen)
Stock Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2018
Innovate Biopharmaceuticals Inc. Senior Note Agreement with Gustavia Capital Partners LLC (January 29, 2018)
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018